tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Globus Medical Announces New CEO and CFO

Story Highlights
  • Globus Medical appointed Keith Pfeil as CEO and Kyle Kline as CFO on July 18, 2025.
  • The company reported a 18.4% increase in Q2 2025 sales, driven by US Spine business growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Globus Medical Announces New CEO and CFO

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from Globus Medical ( (GMED) ).

On July 18, 2025, Globus Medical announced leadership changes with Daniel T. Scavilla resigning as President and CEO, and Keith W. Pfeil appointed as his successor. Pfeil, who has been with the company since 2019, previously served as Chief Operating Officer and Chief Financial Officer. Kyle Kline was also appointed as the new Chief Financial Officer. The company reported preliminary second-quarter sales results, showing an 18.4% increase over the previous year, driven by strong performance in the US Spine business. These leadership transitions and sales results indicate a strategic focus on maintaining growth and innovation in the musculoskeletal technology sector.

The most recent analyst rating on (GMED) stock is a Hold with a $77.00 price target. To see the full list of analyst forecasts on Globus Medical stock, see the GMED Stock Forecast page.

Spark’s Take on GMED Stock

According to Spark, TipRanks’ AI Analyst, GMED is a Outperform.

Globus Medical’s strong financial performance and positive corporate events are significant strengths, supporting a solid overall score. However, high valuation concerns and mixed technical indicators temper the outlook. The earnings call highlighted both challenges and opportunities, contributing to a balanced view.

To see Spark’s full report on GMED stock, click here.

More about Globus Medical

Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and advancing care in spine, orthopedic trauma, joint reconstruction, biomaterials, and enabling technologies.

Average Trading Volume: 1,537,165

Technical Sentiment Signal: Sell

Current Market Cap: $7.63B

See more insights into GMED stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1